Predictors of visual outcome after successful rhegmatogenous retinal detachment repair are identified

Article

Important predictors of postoperative visual outcome after successful successful rhegmatogenous retinal detachment repair have been identified.

Important predictors of postoperative visual outcome after successful successful rhegmatogenous retinal detachment repair have been identified in a study published in Retina.

Dr Magda Gharbiya et al., Department of Ophthalmology, University of Rome, Italy, included 35 patients with preoperative macula-on rhegmatogenous retinal detachment or macula-off rhegmatogenous retinal detachment. All patients underwent scleral buckling surgery and the Early Treatment Diabetic Retinopathy Study was used to measure best-corrected visual acuity (BCVA). Microperimetry and SD-OCT were also conducted on the same day.

SD-OCT was used to measure foveal centre retinal thickness, central 1 mm subfield thickness and outer nuclear layer thickness. The team also assessed the presence or absence of epiretinal membrane, intraretinal fluid and subretinal fluid.

Additionally, the investigation determined the intermediate line as disrupted or complete and identified the status of the external limiting membrane and the inner/outer segment junction. Correlations between SD-OCT findings and postoperative BCVA or retinal sensitivities for central 12° were evaluated.

SD-OCT retinal measurements of the outer nuclear layer thickness strongly correlated with postoperative BCVA and retinal sensitivities. BCVA was also highly correlated with the status of the external limiting membrane, inner/outer segment junction and intermediate line.

Outer nuclear layer thickness and the status of the intermediate line were identified as the most important predictors of visual outcome, as multivariate analysis demonstrated.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.